shot-button
Subscription Subscription
Home > Entertainment News > Bollywood News > Article > Mission Mangal maker Jagan Shakti hospitalised in critical condition

Mission Mangal maker Jagan Shakti hospitalised, in critical condition

Updated on: 26 January,2020 12:32 PM IST  |  Mumbai
mid-day online correspondent |

Mission Mangal director Jagan Shakti has been admitted to the hospital after being diagnosed with a clot in the brain, condition critical.

Mission Mangal maker Jagan Shakti hospitalised, in critical condition

Picture Courtesy: Official Twitter Account/Jagan Shakti

Jagan Shakti, who made his directorial debut with Akshay Kumar, Vidya Balan, Sonakshi Sinha, Taapsee Pannu, Kirti Kulhari, and Sharman Joshi's Mission Mangal, has been hospitalised after being diagnosed with a clot in his brain, as per the media reports.


After hearing about the news, his cousins and family members rushed to the hospital to see the filmmaker. Shakti was supposed to reunite with Kumar for the remake of the blockbuster Tamil potboiler, Kaththi, tentatively titled Ikka, but it seems the project will now be put on a back-burner.


Shakti was the assistant director on R. Balki's Cheeni Kum and Balki also produced his debut, Mission Mangal. The film that was based on the Mars Orbiters Mission became the first 200-crore grosser of Kumar's career and received rave reviews from the critics. It released last year on the eve of Independence Day.


We wish the filmmaker a speedy recovery and he comes back to make a lot more rousing films!

Catch up on all the latest entertainment news and gossip here. Also download the new mid-day Android and iOS apps to get latest updates

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK